Adicet Bio, Inc.
ACET
$8.26
$0.151.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.23% | 0.27% | 2.43% | 13.59% | 16.08% |
| Total Depreciation and Amortization | -6.99% | -1.35% | -0.05% | -0.56% | 0.03% |
| Total Amortization of Deferred Charges | 86.67% | 10.26% | -62.50% | -63.41% | -71.15% |
| Total Other Non-Cash Items | -39.87% | -42.51% | -56.51% | -63.76% | -53.94% |
| Change in Net Operating Assets | 84.06% | 126.66% | 79.43% | 54.95% | -45.39% |
| Cash from Operations | 3.78% | -3.10% | -7.27% | -7.85% | -2.65% |
| Capital Expenditure | 88.06% | -55.46% | -78.48% | -33.67% | 14.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.43% | 103.50% | 127.79% | -- | -- |
| Cash from Investing | 119.80% | 102.01% | 125.51% | -5,497.54% | -4,271.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22,040.47% | -32.26% | -99.64% | -99.64% | -99.69% |
| Repurchase of Common Stock | 37.50% | 26.24% | 53.15% | 62.99% | 62.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 31,665.40% | -32.40% | -99.87% | -99.73% | -99.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.73% | 82.45% | 5.52% | -1,101.91% | -1,457.78% |